Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ENALAPRIL MALEATE USP, with a corresponding US DMF Number 14355.
Remarkably, this DMF maintains an Active status since its submission on June 22, 1999, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 11, 2018, and payment made on December 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II